Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Decibel Cannabis Company Inc

Healthcare CA DB

0.115CAD
-0.005(4.17%)

Last update at 2026-06-05T19:52:00Z

Day Range

0.120.12
LowHigh

52 Week Range

0.060.15
LowHigh

Fundamentals

  • Previous Close 0.12
  • Market Cap74.99M
  • Volume204222
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA3.50M
  • Revenue TTM112.72M
  • Revenue Per Share TTM0.20
  • Gross Profit TTM 41.42M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.92400M 13.59M -3.72600M -4.46200M 1.74M
Minority interest - - - - -
Net income -2.92400M 9.46M -3.72600M -4.46200M 1.74M
Selling general administrative 34.51M 29.92M 30.96M 19.76M 17.31M
Selling and marketing expenses - - - 3.32M 1.16M
Gross profit 41.42M 37.58M 36.70M 26.43M 28.17M
Reconciled depreciation 6.61M 5.04M 3.48M 3.67M 3.74M
Ebit - - - -0.27300M 5.92M
Ebitda - - - 3.40M 9.65M
Depreciation and amortization - - - 3.67M 3.74M
Non operating income net other - - - - -
Operating income 0.30M 2.62M 2.27M -0.71400M 5.97M
Other operating expenses - - - 79.64M 46.48M
Interest expense 2.60M 2.85M 2.76M 3.05M 3.97M
Tax provision 0.00000M 0.00000M 0.00000M 0.01M 0.00000M
Interest income - - - - -
Net interest income -2.65200M -2.90200M -2.86500M -3.15800M -4.09000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 3.20M 4.04M
Total revenue 112.72M 92.54M 114.02M 79.33M 52.45M
Total operating expenses 112.42M 89.92M 111.75M 26.75M 22.20M
Cost of revenue 71.30M 54.96M 77.32M 52.90M 24.28M
Total other income expense net -0.57300M 13.88M -3.13100M -0.98600M -0.13500M
Discontinued operations - - - - -
Net income from continuing ops -2.92400M 13.59M -3.72600M -4.46200M 1.74M
Net income applicable to common shares - - - -4.46200M 1.74M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 141.60M 151.86M 142.99M 140.88M 125.93M
Intangible assets 0.50M 0.96M 0.50M 0.33M 0.42M
Earning assets - - - - -
Other current assets - - - 4.77M 2.46M
Total liab 79.25M 87.14M 96.79M 93.67M 75.19M
Total stockholder equity 62.35M 64.72M 46.20M 47.21M 50.73M
Deferred long term liab - - - - -
Other current liab - 0.22M 1.57M - 0.24M
Common stock - - - 53.53M 53.42M
Capital stock 63.25M 63.23M 54.08M 53.53M 53.42M
Retained earnings -17.64200M -14.71800M -24.18100M -22.41100M -17.94900M
Other liab - - - 0.95M 0.33M
Good will - 0.00000M 4.26M 4.26M 4.26M
Other assets - - - 3.94M 2.41M
Cash 7.49M 7.00M 3.48M 2.97M 1.92M
Cash and equivalents - - - - -
Total current liabilities 45.42M 49.06M 56.69M 53.88M 47.12M
Current deferred revenue - - - - -
Net debt 27.76M 31.23M 37.48M 40.77M 43.56M
Short term debt - - - - -
Short long term debt 8.82M 8.77M 8.62M 8.69M 21.42M
Short long term debt total - - - - -
Other stockholder equity - - - 16.09M 15.26M
Property plant equipment - - - 62.54M 61.53M
Total current assets 60.89M 64.54M 71.48M 69.77M 56.63M
Long term investments - - - - 0.00000M
Net tangible assets - - - 42.59M 45.38M
Short term investments - - - - -
Net receivables 17.16M 11.70M 13.43M 16.61M 12.93M
Long term debt 26.43M 29.46M 32.35M 35.05M 24.06M
Inventory 32.92M 43.34M 50.60M 45.42M 34.66M
Accounts payable 34.03M 38.20M 45.02M 44.33M 24.72M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 2.41M
Deferred long term asset charges - - - - -
Non current assets total 80.71M 87.32M 71.50M 71.11M 69.30M
Capital lease obligations 8.90M 10.10M 7.55M 4.66M 4.42M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 1.19M -2.11500M -3.76400M 0.24M
Change to liabilities - - - 0.00000M 0.00000M
Total cashflows from investing activities - - - -3.76400M -3.22500M
Net borrowings -4.97700M -4.57500M - -3.31400M 5.21M
Total cash from financing activities -4.97700M -1.60000M -3.95900M -3.44700M 18.47M
Change to operating activities - - - -1.22500M -15.84500M
Net income -2.92400M 9.46M -3.72600M -4.46200M 1.74M
Change in cash 0.50M 3.52M -1.01400M 1.05M -1.90100M
Begin period cash flow 7.00M 3.48M 4.41M 1.92M 3.82M
End period cash flow 7.49M 7.00M 3.39M 2.97M 1.92M
Total cash from operating activities 7.46M 3.98M 5.06M 8.26M -17.14600M
Issuance of capital stock - - - 0.00200M 0.27M
Depreciation 6.61M 5.04M 3.48M 3.67M 3.74M
Other cashflows from investing activities - - - 0.06M -0.22200M
Dividends paid - - - - -
Change to inventory -1.29300M 3.26M - - -
Change to account receivables -7.27600M 2.50M - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - 38.39M 23.05M
Change to netincome - - - 10.28M -6.89800M
Capital expenditures 1.98M 1.01M 2.13M 3.82M 3.24M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -9.76400M -6.02700M -9.86200M -1.22500M -15.84500M
Stock based compensation 1.30M -0.87700M 1.52M 1.81M 2.43M
Other non cash items 14.84M 9.49M 13.65M 8.38M -9.24100M
Free cash flow 5.47M 2.97M 2.93M 4.44M -20.38900M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DB
Decibel Cannabis Company Inc		 -0.005 4.17% 0.12 - 8.67 0.67 1.20 0.99 17.75
RX
Biosyent Inc.		 -0.3 2.14% 13.70 19.10 15.85 3.96 4.11 3.31 11.03
ZYUS
ZYUS Life Sciences Corporation		 - -% 0.50 - - 108.48 4.41 140.29 -4.258
LSL
LSL Pharma Group Inc.		 - -% 0.33 20.75 - 1.88 1.89 2.85 10.19
ROMJ
Rubicon Organics Inc		 -0.005 1.14% 0.43 28.50 38.02 0.65 0.87 0.79 9.17

Reports Covered

Stock Research & News

View All

Profile

Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation in Canada. It is involved in the extraction, processing, and manufacturing of vape cartridges and glass tube packaging for pre-rolls. The company also engages in the business-to-business cannabis product sales in the provinces of Saskatchewan and Alberta; and e-commerce end-user customers in the province of Saskatchewan. It offers its products under the Qwest, Vox, Blendcraft, and General Admission brands. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.

Decibel Cannabis Company Inc

140 - 4th Avenue SW, Calgary, AB, Canada, T2P 3N3

Key Executives

Name Title Year Born
Mr. Paul Wilson CEO & Director 1958
Mr. Stuart Boucher Chief Financial Officer NA
Mr. Adam Coates Chief Revenue Officer 1988
Mr. Kris Newell Chief Operating Officer NA
Mr. Gary Joseph Leong Chief Compliance Officer 1965
Mr. Derek Sider Chief Commercial Officer NA
Mr. Christian Monson Chief Legal Officer & VP of Strategy of Westleaf International Inc. NA
Mr. Benjamin Sze Chief Executive Officer 1983
Jesse Martin General Counsel & Corporate Secretary NA
Mr. Benjamin Sze CEO & Director 1982

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.